HomeLatest NewsFederal NewsOpioid bill awaits president’s signature

Opioid bill awaits president’s signature

Last week the Senate voted 98-1 to pass the major opioid legislative package it had negotiated with the House. The bill now awaits President Trump’s signature.

The House and Senate mostly agreed on major provisions of the legislation, however language that would let Medicare pay more for opioid alternatives that treat post-surgical pain did not make the final cut. Also not included was a fiscal offset that would have saved government funds by requiring employer-paid plans to cover more care for end-stage renal disease.

Click here to view a comparison of select provisions of the House and Senate bills and what was included in the final opioid bill.

Stay Connected

Unified Voice Newsletter

Events This Month


25junAll Day262024 Rural Health Leaders ConferenceSDAHO Event

25jun12:00 pm1:00 pmData Protection and Recovery - Tales from the TrenchesAHA Webinar

26jun12:00 pm1:00 pmProtecting Mothers: Key Takeaways From the 2024 Maternal Mortality and Morbidity Prevention ReportAHA Webinar

27jun11:00 am12:00 pmHire Smart: How to Interview, Select, and Onboard the Right PeopleSDAHO Webinar

27jun11:30 am12:30 pmPsychosocial Needs of Cancer Patients from an Ethnically Diverse Underserved CommunityMJHS Hospice and Palliative Care Webinar

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact